Tin tức & Cập nhật
Xem bài viết Sản phụ khoa
Xem
Chỉ hiển thị Multimedia

Nonhormonal drug for hot flash scores big in two phase III trials
02 Nov 2024
bởiJairia Dela Cruz
The novel neurokinin-1 and -3 receptor antagonist elinzanetant appears to reduce the frequency and severity of vasomotor symptoms (VMS), as well as improve sleep and menopause-related quality of life, as shown in two pivotal phase III trials.
02 Nov 2024

Induction chemo followed by chemoradiotherapy bumps up survival in advanced cervical cancer
21 Oct 2024
A short-course induction chemotherapy conducted prior to chemoradiotherapy appears to deliver significant survival boost in locally advanced cervical cancer, according to the phase III GCIG INTERLACE trial.
21 Oct 2024






